Balanced Salt Solution Versus 0.9% Saline Infusion for Prevention of Contrast-induced Acute Kidney Injury (BASIC Trial)
A Randomized, Open Label, Active Control, 2 Parallel Groups, Multicenter, Phase III Study to Evaluate the Efficacy and Safety of Balanced Salt Solution Versus 0.9% Saline in Patients With High Risk of Contrast Induced Nephropathy.
Sponsor: Bundang CHA Hospital
Listed as NCT02799368, this PHASE3 trial focuses on Acute Kidney Injury and Contrast Media Reaction and remains completed. Sponsored by Bundang CHA Hospital, it has been updated 9 times since 2016, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
9 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE3
-
Nov 2020 — Jan 2021 [monthly]
Completed PHASE3
Status: Recruiting → Completed
▶ Show 4 earlier versions
-
Oct 2019 — Nov 2020 [monthly]
Recruiting PHASE3
-
Jun 2018 — Oct 2019 [monthly]
Recruiting PHASE3
-
Oct 2017 — Jun 2018 [monthly]
Recruiting PHASE3
Status: Not Yet Recruiting → Recruiting
-
Jan 2017 — Oct 2017 [monthly]
Not Yet Recruiting PHASE3
First recorded
Nov 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Bundang CHA Hospital
- Ewha Womans University Mokdong Hospital
- Gachon University Gil Medical Center
- Incheon St.Mary's Hospital
- Kyungpook National University Hospital
- National Health Insurance Service Ilsan Hospital
- National Medical Center, Seoul
- Seoul National University Boramae Hospital
- Seoul National University Bundang Hospital
- Seoul National University Hospital
- Seoul St. Mary's Hospital
- Severance Hospital
For direct contact, visit the study record on ClinicalTrials.gov .